Zai Lab Ltd
- CIK: 0001704292
- EIN: 00-0000000
- Business address: 4560 JINKE ROAD, BLDG. 1, 4F, PUDONG, SHANGHAI, China, 201210
Information
Mailing address
4560 JINKE ROAD, BLDG. 1, 4F, PUDONG, SHANGHAI, Cayman Islands, 201210Phone
862161632588State location
ChinaState of incorporation
Cayman IslandsFiscal year end
December 31SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONSFilings
N/A
About Zai Lab Ltd
Zai Lab Ltd (CIK: 0001704292) is an American company incorporated in the state of China. Head office is located at 4560 JINKE ROAD, BLDG. 1, 4F, PUDONG, SHANGHAI, China, 201210. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Zai Lab Ltd is a public company and trade via Over-The-Counter (OTC).Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Chen Yajing | 0001985694 | Aug-14-2023 | officer: Chief Financial Officer |
| Vounatsos Michel | 0001672709 | Jan-07-2023 | director |
| Amado Rafael | 0001662119 | Dec-30-2022 | officer: See Remarks |
| Smiley Joshua L | 0001725189 | Aug-15-2022 | officer: Chief Operating Officer |
| GAYNOR RICHARD | 0001741284 | Nov-19-2021 | director |
| Morrison Scott W | 0001662426 | Oct-13-2021 | director |
| WIRTH PETER | 0001021041 | Jan-01-2021 | director |
| MOULDER LEON O JR | 0001228865 | Jan-01-2021 | director |
| DIEKMAN JOHN D | 0001240357 | Jan-01-2021 | director |
| Lis William | 0001574558 | Jan-01-2021 | director |
| Qiming Venture Partners IV, L.P. | 0001603597 | Jan-01-2021 | 10 percent owner |
| Qiming Managing Directors Fund IV, L.P. | 0001605610 | Jan-01-2021 | 10 percent owner |
| Fu Tao | 0001644888 | Jan-01-2021 | director, officer: President & COO |
| Du Ying | 0001731790 | Jan-01-2021 | director, officer: Chairwoman & CEO |
| Edmondson Frazor Titus III | 0001835780 | Jan-01-2021 | officer: Chief Legal Officer |
| Leung Nisa | 0001835822 | Jan-01-2021 | director |
| Reinhart Harald | 0001835824 | Jan-01-2021 | officer: Chief Medical Officer |
| Liang Yi | 0001835832 | Jan-01-2021 | officer: CCO & President, Greater China |
| Cho William Ki Chul | 0001835836 | Jan-01-2021 | officer: Chief Financial Officer |
| Sandler Alan B. | 0001835966 | Jan-01-2021 | officer: Head of Global Dev., Oncology |
| Chen Kai-Xian | 0001836195 | Jan-01-2021 | director |
| QM 11 Ltd | 0001838417 | Jan-01-2021 | 10 percent owner |
| Qiming GP IV, L.P. | 0001838789 | Jan-01-2021 | 10 percent owner |
| Qiming Corporate GP IV, Ltd | 0001839126 | Jan-01-2021 | 10 percent owner |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Zai Lab Ltd
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001422848-24-000207 (34 Act) Size: 17 KB |
Feb-09-2024 | 24617983 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000315066-24-001550 (34 Act) Size: 8 KB |
Feb-09-2024 | 24612655 |
| 8-K | Document | Current report filing Acc-no: 0001628280-24-003902 (34 Act) Size: 8759 KB |
Feb-08-2024 | 24609685 |
| SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902219-24-000028 (34 Act) Size: 36 KB |
Feb-08-2024 | 24607227 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000914208-24-000055 (34 Act) Size: 17 KB |
Feb-01-2024 | 24586814 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000905148-24-000063 ( Act) Size: 12 KB |
Jan-03-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000905148-24-000062 ( Act) Size: 10 KB |
Jan-03-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000905148-24-000061 ( Act) Size: 10 KB |
Jan-03-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000905148-24-000060 ( Act) Size: 10 KB |
Jan-03-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-24-000080 (33 Act) Size: 4 KB |
Jan-03-2024 | 24506069 |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-24-000079 (33 Act) Size: 4 KB |
Jan-03-2024 | 24506039 |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-24-000075 (33 Act) Size: 4 KB |
Jan-03-2024 | 24506000 |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-24-000034 (33 Act) Size: 4 KB |
Jan-02-2024 | 24502202 |
| 10-K/A | Document | Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001628280-23-042643 (34 Act) Size: 455 KB |
Dec-22-2023 | 231510213 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000905148-23-001614 ( Act) Size: 4 KB |
Dec-18-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000905148-23-001471 ( Act) Size: 4 KB |
Nov-16-2023 | |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001628280-23-037358 (34 Act) Size: 8970 KB |
Nov-07-2023 | 231384080 |
| 8-K | Document | Current report filing Acc-no: 0001628280-23-037353 (34 Act) Size: 404 KB |
Nov-07-2023 | 231383814 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000905148-23-001298 ( Act) Size: 8 KB |
Nov-03-2023 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-23-004492 (33 Act) Size: 4 KB |
Nov-02-2023 | 231371778 |
Recent 20 filings. View all Zai Lab Ltd filings
Reviews
Ryan Storey
Huge help thank you for your help .. y'all make it so much easier
Pelisari
young lad who new his job ansered questions and new what was best for me.
Jean Bishop
Very good communication and delivery made within the timeframe I was advised of
Frequently Asked Questions
Tags:
- Zai Lab Ltd overview
- Zai Lab Ltd job
- Zai Lab Ltd stock
- Zai Lab Ltd ownership
- Zai Lab Ltd CEO
- Zai Lab Ltd documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Contineum Therapeutics, Inc.
Update: Mar 16, 2024
Cuprina Holdings (Cayman) LTD
Update: Mar 08, 2024
APRINOIA Therapeutics Inc.
Update: Jan 27, 2024
Zhengye Biotechnology Holding Ltd
Update: Jan 10, 2024
Alto Neuroscience, Inc.
Update: Nov 28, 2023
Mural Oncology plc
Update: Nov 02, 2023
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 